Dec 18, 2014 at 12:34 | Source: CNBC-TV18
Nirmal Jain, Chairman at IIFL is of the view that one may prefer banking, IT and pharma stocks.
Dec 18, 2014 at 10:58 | Source: CNBC-TV18
Ambareesh Baliga, Independent Market Expert is of the view that one may buy Infosys, HCL Technologies and Sun Pharmaceutical Industries.
Dec 17, 2014 at 17:04 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Asian Paints for long term.
Dec 16, 2014 at 08:26 | Source: CNBC-TV18
Sun Pharma | Ranbaxy Labs | Maruti Suzuki | IDBI Bank | JP Associates | IOC | SpiceJet | Apollo Hospitals | CESC | Hindalco | Motherson Sumi | Indian Hotels | State Bank of Travancore | Seamec | Electrosteel Castings | Omaxe | Lloyd Electric | KEC International | Kolte-Patil Developers and Tree House are stocks, which are in the news today.
Dec 15, 2014 at 21:14 | Source: CNBC-TV18
As a result of its post merger consultation with the US Federal Trade Commission (FTC), the Sun-Ranbaxy combine will most probably have to sell just one drug for the merger to get the green light.
Dec 15, 2014 at 14:47 | Source: CNBC-TV18
Kunal Bothra of LKP Securities recommends buying Sun Pharma and State Bank of India.
Dec 15, 2014 at 11:18 | Source: CNBC-TV18
Hemant Thukral of Aditya Birla Money is of the view that Sun Pharma is a good bet and has a target of Rs 875.
Dec 15, 2014 at 09:13 | Source: CNBC-TV18
According to Hemant Thukral of Aditya Birla Money, one can buy Sun Pharma with a target of Rs 875 and sell HCL Tech with a target of Rs 1480.
Dec 15, 2014 at 08:55 | Source: CNBC-TV18
In an interview to CNBC-TV18, Sudarshan Sukhani of s2analytics.com shares his view on the market and shares his insight on particular stocks.
Dec 15, 2014 at 08:46 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com feels that Sun Pharmaceutical Industries could remain an outperformer.